Parameter Constraints and Boundary Solutions

Why Parameter Constraints Matter

An Emax curve can be biologically sensible yet numerically difficult to estimate. The optimizer may explore negative half-maximal concentrations, nonpositive Hill coefficients, or response magnitudes inconsistent with the direction and scale of the effect. Constraints can exclude such values. But they also change the estimation problem: if a parameter estimate lands exactly on a bound, the data may be pressing against that limit, or the parameter may be weakly identified and the bound may be deciding its value.

The earlier material on scaling and reparameterizing Emax models, starting values, nonlinear least squares, and residual error provides the fitting context. Here the focus is how to choose and interpret bounds. A constraint is not a substitute for information in the concentration-response data: it should rule out implausible values, not manufacture apparent certainty.

Definition: A parameter constraint restricts the values that a model parameter may take during estimation. A solution is a boundary solution when one or more estimated parameters equal a specified lower or upper bound. The bound is active at that solution; a parameter strictly between its bounds is interior.

Parameter Bounds in Emax Models

For a baseline-relative direct-effect model, write the expected response at concentration \(C\) as

E(C)=E_0+E_{\max}\frac{C^\gamma}{EC_{50}^\gamma+C^\gamma}, \qquad C\geq 0.

Here \(E_0\) is the response at zero concentration, \(E_{\max}\) is the maximum change from baseline as concentration increases without bound, \(EC_{50}\) is the concentration giving half of that change, and \(\gamma\) controls the steepness of the curve. For this parameterization, \(EC_{50}>0\) and \(\gamma>0\) are required for the usual increasing, saturating response curve. The sign of \(E_{\max}\) depends on effect direction: it is positive for an increase and negative for a decrease in response. An inhibitory model written with a positive magnitude and a minus sign has the equivalent direction encoded differently.

A biologically meaningful bound on \(E_{\max}\) must therefore respect the response definition and units. If response is bounded, such as a percentage, a defensible upper or lower limit may follow from that scale. If the response is an unbounded measurement, the biology may justify a sign but not a narrow maximum magnitude. The same caution applies to \(EC_{50}\): positivity is generally necessary, but an upper bound should come from external knowledge or a clearly stated plausible domain, not merely from a desire to obtain a finite estimate. A positive \(\gamma\) is standard for the increasing sigmoid form; any narrower range needs justification.

Bounds may be imposed directly, such as \(L\leq EC_{50}\leq U\), or positivity may be ensured through a transformation such as \(EC_{50}=\exp(\eta)\). A transformation guarantees positivity but does not impose a scientifically justified finite upper bound. It also changes the numerical parameter being optimized: an optimizer’s step in \(\eta\) is not a fixed step in \(EC_{50}\).

Worked Example: Choosing Bounds From the Response Scale

Suppose a hypothetical assay measures percent inhibition, with larger values meaning greater inhibition. The model is parameterized as a positive magnitude of inhibition:

E(C)=E_0+E_{\max}\frac{C^\gamma}{EC_{50}^\gamma+C^\gamma}.

The assay response is a percentage from 0 to 100, and the estimated baseline is \(E_0=4\) percentage points. If the mechanism and assay definition imply the drug cannot produce more than 96 additional percentage points of inhibition above this baseline, a possible bound is \(0\leq E_{\max}\leq 96\) percentage points. The model also requires \(EC_{50}>0\) in the concentration units used, and \(\gamma>0\).

For illustration, suppose concentration is measured in mg/L and external evidence supports a plausible range of 0.01 to 100 mg/L for \(EC_{50}\), while prior mechanistic knowledge supports \(0.5\leq\gamma\leq 3\). These ranges are hypotheses to justify and report, not universal defaults. In particular, an \(EC_{50}\) bound should not be narrowed just because the observed concentrations do not cover a wider range; that would convert a design limitation into an apparently precise estimate.

The bounds on \(E_{\max}\) are meaningful only for this positive-magnitude parameterization. If instead \(E_{\max}\) represents a signed change from baseline, the corresponding inhibition may require \(E_{\max}\leq 0\). The model’s parameterization and units must be checked before choosing signs or limits.

What a Boundary Solution Means

In nonlinear least squares, an optimizer chooses allowed parameter values to minimize an objective such as the weighted sum of squared residuals,

Q(\boldsymbol{\theta})=\sum_{i=1}^{n}w_i\left[y_i-E(C_i;\boldsymbol{\theta})\right]^2,

where \(y_i\) is the observed response at concentration \(C_i\), \(\boldsymbol{\theta}\) is the vector of model parameters, and \(w_i\) is the specified weight. Constraints define the allowed region over which \(Q\) is minimized. If the unconstrained minimum lies outside that region, the constrained minimum can occur on its boundary.

For a single parameter \(\theta\) constrained to \(L\leq\theta\leq U\), a differentiable objective minimized at the lower boundary must have \(Q'(\theta)\geq 0\) there: moving right cannot reduce the objective. At the upper boundary it must have \(Q'(\theta)\leq 0\): moving left cannot reduce the objective. These directional conditions explain why the ordinary condition \(Q'(\theta)=0\) need not hold at a constrained solution. In multiple dimensions, the analogous conditions apply to feasible directions; a boundary estimate need not be a stationary point of the unconstrained objective.

Worked Example: An Upper-Bound Solution for EC50

Consider a hypothetical, noiseless Emax curve with \(E_0=0\), \(E_{\max}=80\) response units, and \(\gamma=1\). The three observations are generated at \(C=0.1,\ 0.2,\ 0.4\) mg/L using \(EC_{50}=120\) mg/L, then rounded to four significant figures. Fit only \(EC_{50}\), with the imposed range \(1\leq EC_{50}\leq100\) mg/L.

The observations are approximately \(0.06661,\ 0.1331,\ 0.2658\) response units. At the upper bound, \(EC_{50}=100\) mg/L, the model predictions are:

\begin{aligned} E(0.1)&=\frac{80(0.1)}{100+0.1}=0.0799201\approx0.07992,\\ E(0.2)&=\frac{80(0.2)}{100+0.2}=0.159681\approx0.1597,\\ E(0.4)&=\frac{80(0.4)}{100+0.4}=0.318725\approx0.3187. \end{aligned}

With equal weights, the sum of squared residuals at the upper bound is approximately

Q(100)=(0.0799201-0.06661)^2+(0.159681-0.1331)^2+(0.318725-0.2658)^2\approx0.003685.

For any of these positive concentrations, the prediction \(80C/(EC_{50}+C)\) decreases as \(EC_{50}\) increases. Because the generated observations correspond to \(EC_{50}=120\) mg/L, predictions for every allowed value \(EC_{50}\leq100\) exceed the unrounded observations. Increasing \(EC_{50}\) toward 100 therefore reduces each positive residual and reduces \(Q\). The constrained minimum is at 100 mg/L, even though the generating value is outside the allowed range. This is a boundary solution, not evidence that the drug’s true \(EC_{50}\) is 100 mg/L. It indicates that the data and the chosen range push the estimate to the largest allowed value.

Justifying and Diagnosing Constraints

A constraint is most defensible when its basis is independent of the fit being performed: response-scale limits, known direction of effect, physical positivity, or external mechanistic information. It is less defensible when chosen after inspecting the data to make the optimizer converge or to force a desired estimate. Report the parameterization, units, bounds, and whether any estimate reached a bound.

A practical diagnosis asks whether the bound is genuinely excluding impossible values or substituting for missing information. Check the following:

Active-bound status: determine whether the estimate is exactly at a bound or merely close, allowing for numerical tolerance. Record which bound is active.
Objective behavior: compare the objective at the solution with feasible nearby values. At an upper boundary, moving inward should not improve the objective if the solution is valid.
Starting values and convergence: fit from several scientifically reasonable starting points. Different boundary solutions, failed convergence, or large changes in estimates warrant investigation.
Sensitivity to bounds: if modest, defensible changes to a bound substantially change the estimate while barely changing fitted predictions or the objective, the parameter is weakly informed by these data.
Data coverage: check whether concentrations span the transition and plateau needed to estimate the parameters. A boundary estimate of \(EC_{50}\) or \(\gamma\) is especially hard to interpret when the observed range does not reveal the relevant curve shape.

A successful optimizer exit is not itself a diagnostic of identifiability. Conversely, a boundary estimate is not automatically an optimization failure: if the constraint is justified and the objective is minimized over the allowed region, it is a valid constrained solution. The concern is interpretation, especially when the limit was introduced for numerical convenience rather than biological reasons.

Worked Example: When Bounds Conceal Weak Identification

Suppose concentrations are only 1, 2, and 4 mg/L, all low relative to a plausible \(EC_{50}\). For \(\gamma=1\), the response increment is

\Delta E=E_{\max}\frac{C}{EC_{50}+C}.

When \(C\) is small relative to \(EC_{50}\), dividing numerator and denominator by \(EC_{50}\) gives \(\Delta E=(E_{\max}/EC_{50})C/[1+C/EC_{50}]\), which is approximately \((E_{\max}/EC_{50})C\) when \(C/EC_{50}\) is small. Thus these low-concentration observations primarily inform the ratio \(E_{\max}/EC_{50}\), not both parameters separately.

For example, the parameter pair \(E_{\max}=100\) response units and \(EC_{50}=50\) mg/L predicts increments of \(100(1)/(50+1)=1.9608\), \(100(2)/(50+2)=3.8462\), and \(100(4)/(50+4)=7.4074\) response units. The pair \(E_{\max}=200\) response units and \(EC_{50}=100\) mg/L predicts \(1.9802,\ 3.9216,\ 7.6923\) response units at the same concentrations. The predictions are similar over this low range, although the parameter values differ substantially. With measurement error, the data may not distinguish them well.

If a fit returns \(EC_{50}=50\) mg/L because that was imposed as an upper bound, and \(E_{\max}=100\), the exact-looking values do not establish that both parameters are well estimated. Change the defensible bound and examine whether the fit and estimates move. A constraint can provide a stable, usable estimate under explicit prior assumptions, but it cannot create concentration information that was never collected.

Alternatives, Limitations, and Common Pitfall

Bounds are one way to ensure estimates remain in a plausible region. A log transformation, such as \(EC_{50}=\exp(\eta)\), enforces positivity without a hard finite limit. This can improve numerical behavior, but it cannot prevent estimates from becoming extremely large and does not resolve weak identification. Direct bounds make a finite allowed range explicit, but they can produce active-bound estimates and can make inference sensitive to the chosen limits. Reparameterization can reduce scale problems or encode relationships among parameters; it likewise does not add information to the data. Penalty methods discourage values in a region rather than strictly forbidding them, so their effect depends on the penalty strength and should not be confused with a hard biological constraint.

All these approaches have limitations. A bound may be wrong, prior knowledge may not transfer to the study population or assay, and constrained standard-error approximations can be unreliable near a boundary. A good fit within the allowed region does not establish that the region itself is correct. For weakly identified parameters, report the constraint and avoid presenting a boundary estimate as if it were determined precisely by the observations.

Common mistake: “The optimizer converged at the maximum allowed \(EC_{50}\), so the data estimate \(EC_{50}\) to be that value.” This reasoning confuses a constrained optimum with evidence that the parameter equals the imposed limit. The correction is to say that the optimum occurred at the upper bound, then examine objective behavior, data coverage, and sensitivity to defensible alternative bounds. If the bound was not independently justified, the result is a warning about the estimation problem, not a biological conclusion.

Key takeaway: Impose bounds that have a scientific basis, check whether any estimate is active at a bound, and assess how much the fit depends on the limits. A constraint can exclude implausible values; it cannot repair weak identification.

Check Your Understanding

Answer each question, then compare with the solutions below.

In the increasing Emax model, why are \(EC_{50}\) and \(\gamma\) ordinarily constrained to be positive?
For an objective minimized over \(L\leq\theta\leq U\), what directional derivative condition applies at an upper-bound minimum?
A fitted \(EC_{50}\) equals its imposed upper bound. State one appropriate interpretation and one conclusion that should not be drawn automatically.
What feature of low-concentration data makes \(E_{\max}\) and \(EC_{50}\) difficult to estimate separately when \(\gamma=1\)?
A log transformation keeps \(EC_{50}\) positive. Does it impose a finite upper bound or resolve weak identification?

Solutions. (1) Positive values give the usual increasing, saturating form with a positive half-maximal concentration and a positive Hill coefficient. (2) At an upper-bound minimum, \(Q'(\theta)\leq0\); moving left must not reduce the objective. (3) The constrained optimum is at the largest allowed value, so report the active upper bound and investigate sensitivity. Do not conclude automatically that the true parameter equals the bound. (4) When \(C\ll EC_{50}\), the increment is approximately \((E_{\max}/EC_{50})C\); the data mainly inform the ratio rather than each parameter. (5) No. The transformation enforces positivity, but it gives no finite upper limit and does not resolve weak identification.